Page last updated: 2024-08-23

nigericin and Angiogenesis, Pathologic

nigericin has been researched along with Angiogenesis, Pathologic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Alsaadi, M; Arkhipova, SS; Garanina, EE; Gilazieva, ZE; Hamza, S; Khaiboullina, SF; Markelova, MI; Martinova, EV; McIntyre, A; Rizvanov, AA; Tezcan, G	1

Other Studies

1 other study(ies) available for nigericin and Angiogenesis, Pathologic

Article	Year
Therapeutic Potential of Pharmacological Targeting NLRP3 Inflammasome Complex in Cancer. Frontiers in immunology, 2020, Volume: 11 Topics: A549 Cells; Antineoplastic Agents; Cell Proliferation; Cell Survival; Cytokines; Dipeptides; Humans; Inflammasomes; Inflammation Mediators; MCF-7 Cells; Mitochondria; Molecular Targeted Therapy; Neoplasms; Neovascularization, Pathologic; Nigericin; NLR Family, Pyrin Domain-Containing 3 Protein; para-Aminobenzoates; PC-3 Cells; Signal Transduction	2020

Article

Year

Therapeutic Potential of Pharmacological Targeting NLRP3 Inflammasome Complex in Cancer.

Frontiers in immunology, 2020, Volume: 11

Topics: A549 Cells; Antineoplastic Agents; Cell Proliferation; Cell Survival; Cytokines; Dipeptides; Humans; Inflammasomes; Inflammation Mediators; MCF-7 Cells; Mitochondria; Molecular Targeted Therapy; Neoplasms; Neovascularization, Pathologic; Nigericin; NLR Family, Pyrin Domain-Containing 3 Protein; para-Aminobenzoates; PC-3 Cells; Signal Transduction

2020